Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples.

Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples.

Item
http://www.wikidata.org/entity/Q34070279
An improved ultra-performance liquid chromatography-electrospray ionization/quadrupole-time-of-flight high-definition mass spectrometry method for determining ingredients of herbal Fructus corni in blood samplesProteomics analysis of hepatoprotective effects for scoparone using MALDI-TOF/TOF mass spectrometry with bioinformaticsProfiling and identification of the absorbed constituents and metabolites of schisandra lignans by ultra-performance liquid chromatography coupled to mass spectrometry.Ultra-performance liquid-chromatography with tandem mass spectrometry for rapid analysis of pharmacokinetics, biodistribution and excretion of schisandrin after oral administration of Shengmaisan.Metabolomics coupled with proteomics advancing drug discovery toward more agile development of targeted combination therapies.Advancing drug discovery and development from active constituents of yinchenhao tang, a famous traditional chinese medicine formula.Potentiating therapeutic effects by enhancing synergism based on active constituents from traditional medicine.Mass spectrometry-driven drug discovery for development of herbal medicine.Characterization of the multiple components of Acanthopanax Senticosus stem by ultra high performance liquid chromatography with quadrupole time-of-flight tandem mass spectrometry.Optimization of the extraction process for the seven bioactive compounds in Yukmijihwang-tang, an herbal formula, using response surface methodology.Prediction of Human Pharmacokinetics from Preclinical Information of Rhein, an Antidiabetic Nephropathy Drug, Using a Physiologically Based Pharmacokinetic Model
P2860

Simultaneous in vivo RP-HPLC-DAD quantification of multiple-component and drug-drug interaction by pharmacokinetics, using 6,7-dimethylesculetin, geniposide and rhein as examples.

Item
http://www.wikidata.org/entity/Q34070279
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@ast
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@en
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@nl
type
label
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@ast
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@en
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@nl
prefLabel
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@ast
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@en
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P577
P698
P356
P1433
P1476
Simultaneous in vivo RP-HPLC-D ...... iposide and rhein as examples.
@en
P2093
P2860
P304
P31
P356
P433
P478
P577
P698